UBE2S_HUMAN - dbPTM
UBE2S_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UBE2S_HUMAN
UniProt AC Q16763
Protein Name Ubiquitin-conjugating enzyme E2 S
Gene Name UBE2S
Organism Homo sapiens (Human).
Sequence Length 222
Subcellular Localization
Protein Description Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. [PubMed: 22496338 Catalyzes 'Lys-11'-linked polyubiquitination. Acts as an essential factor of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated ubiquitin ligase that controls progression through mitosis. Acts by specifically elongating 'Lys-11'-linked polyubiquitin chains initiated by the E2 enzyme UBE2C/UBCH10 on APC/C substrates, enhancing the degradation of APC/C substrates by the proteasome and promoting mitotic exit]
Protein Sequence MNSNVENLPPHIIRLVYKEVTTLTADPPDGIKVFPNEEDLTDLQVTIEGPEGTPYAGGLFRMKLLLGKDFPASPPKGYFLTKIFHPNVGANGEICVNVLKRDWTAELGIRHVLLTIKCLLIHPNPESALNEEAGRLLLENYEEYAARARLLTEIHGGAGGPSGRAEAGRALASGTEASSTDPGAPGGPGGAEGPMAKKHAGERDKKLAAKKKTDKKRALRRL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MNSNVENL
-------CCCCHHHC
12.8419413330
18UbiquitinationHIIRLVYKEVTTLTA
HHHHHHEEEEEECCC
37.9221963094
32UbiquitinationADPPDGIKVFPNEED
CCCCCCEEECCCHHH
43.2733845483
63AcetylationAGGLFRMKLLLGKDF
CCCEEHEEHHHCCCC
31.5525953088
63UbiquitinationAGGLFRMKLLLGKDF
CCCEEHEEHHHCCCC
31.5523000965
68AcetylationRMKLLLGKDFPASPP
HEEHHHCCCCCCCCC
57.0590475
682-HydroxyisobutyrylationRMKLLLGKDFPASPP
HEEHHHCCCCCCCCC
57.05-
68UbiquitinationRMKLLLGKDFPASPP
HEEHHHCCCCCCCCC
57.0523000965
73PhosphorylationLGKDFPASPPKGYFL
HCCCCCCCCCCCEEE
41.8130266825
76UbiquitinationDFPASPPKGYFLTKI
CCCCCCCCCEEEEEE
70.4027667366
78PhosphorylationPASPPKGYFLTKIFH
CCCCCCCEEEEEECC
11.0926074081
81PhosphorylationPPKGYFLTKIFHPNV
CCCCEEEEEECCCCC
16.52-
82UbiquitinationPKGYFLTKIFHPNVG
CCCEEEEEECCCCCC
45.5921963094
82AcetylationPKGYFLTKIFHPNVG
CCCEEEEEECCCCCC
45.5926051181
100UbiquitinationEICVNVLKRDWTAEL
EEEEEECCCCCHHHH
43.9923000965
100AcetylationEICVNVLKRDWTAEL
EEEEEECCCCCHHHH
43.9925953088
117UbiquitinationRHVLLTIKCLLIHPN
HHHHHEEEEEECCCC
17.3721906983
152PhosphorylationAARARLLTEIHGGAG
HHHHHHHHHHHCCCC
37.17-
162PhosphorylationHGGAGGPSGRAEAGR
HCCCCCCCHHHHHHH
44.1628555341
173PhosphorylationEAGRALASGTEASST
HHHHHHHCCCCCCCC
47.2826074081
175PhosphorylationGRALASGTEASSTDP
HHHHHCCCCCCCCCC
26.3618669648
178PhosphorylationLASGTEASSTDPGAP
HHCCCCCCCCCCCCC
27.7828555341
179PhosphorylationASGTEASSTDPGAPG
HCCCCCCCCCCCCCC
43.8328985074
180PhosphorylationSGTEASSTDPGAPGG
CCCCCCCCCCCCCCC
43.6621712546
195SulfoxidationPGGAEGPMAKKHAGE
CCCCCCCHHHHCCCH
14.5321406390
197AcetylationGAEGPMAKKHAGERD
CCCCCHHHHCCCHHH
38.5525953088
197UbiquitinationGAEGPMAKKHAGERD
CCCCCHHHHCCCHHH
38.5521963094
198UbiquitinationAEGPMAKKHAGERDK
CCCCHHHHCCCHHHH
29.2022817900

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
152TPhosphorylationKinaseAKT1P31749
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UBE2S_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UBE2S_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HOIL1_HUMANRBCK1physical
19549727
FZR1_HUMANFZR1physical
19822757
CDC20_HUMANCDC20physical
19822757
CDC27_HUMANCDC27physical
19822757
UBE2S_HUMANUBE2Sphysical
20622874
UBC_HUMANUBCphysical
20622874
UBC_HUMANUBCphysical
21376237
UBE2S_HUMANUBE2Sphysical
8576261
A4_HUMANAPPphysical
21832049
ZCH18_HUMANZC3H18physical
22939629
UBFD1_HUMANUBFD1physical
22939629
UBP10_HUMANUSP10physical
22939629
ZC3HE_HUMANZC3H14physical
22939629
ZN598_HUMANZNF598physical
22939629
VATA_HUMANATP6V1Aphysical
22939629
ANC2_HUMANANAPC2physical
23708001
CDC23_HUMANCDC23physical
23708001
FZR1_HUMANFZR1physical
23708001
FBX5_HUMANFBXO5physical
23708001
UBE2S_HUMANUBE2Sphysical
20061386
UBE2S_HUMANUBE2Sphysical
25306923
APC1_HUMANANAPC1physical
25306923
ANC2_HUMANANAPC2physical
25306923
APC4_HUMANANAPC4physical
25306923
CDC27_HUMANCDC27physical
25306923
APC5_HUMANANAPC5physical
25306923
CDC16_HUMANCDC16physical
25306923
APC7_HUMANANAPC7physical
25306923
CDC23_HUMANCDC23physical
25306923
APC11_HUMANANAPC11physical
25306923
FZR1_HUMANFZR1physical
25306923
CDC20_HUMANCDC20physical
25306923
KC1E_HUMANCSNK1Ephysical
26186194
CBP_HUMANCREBBPphysical
26344197
SYNC_HUMANNARSphysical
26344197
HNRPQ_HUMANSYNCRIPphysical
26344197
US6NL_HUMANUSP6NLphysical
26496610
BRE1B_HUMANRNF40physical
26496610
RUSC1_HUMANRUSC1physical
26496610
ELMO3_HUMANELMO3physical
26496610
UBB_HUMANUBBphysical
26828794
ANC2_HUMANANAPC2physical
25306918
APC11_HUMANANAPC11physical
25306918
CDC20_HUMANCDC20physical
25306918
UBC_HUMANUBCphysical
25306918
CDC23_HUMANCDC23physical
25306918
FZR1_HUMANFZR1physical
25306918
UBE2S_HUMANUBE2Sphysical
27685940
VHL_HUMANVHLphysical
27685940
RBX2_HUMANRNF7physical
27910872
UBE2C_HUMANUBE2Cphysical
27910872
UB2D3_HUMANUBE2D3physical
27910872
AKT1_HUMANAKT1physical
27593939
SVOPL_HUMANSVOPLphysical
27593939
PMF1_HUMANPMF1physical
27593939
DPM3_HUMANDPM3physical
27593939
XRCC6_HUMANXRCC6physical
27593939
HSP7C_HUMANHSPA8physical
27593939
XRCC5_HUMANXRCC5physical
27593939
NUCL_HUMANNCLphysical
27593939
SRP68_HUMANSRP68physical
27593939
HS71L_HUMANHSPA1Lphysical
27593939
IF2B1_HUMANIGF2BP1physical
27593939
HNRPR_HUMANHNRNPRphysical
27593939
GRP78_HUMANHSPA5physical
27593939

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UBE2S_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.

TOP